Although COVID-19 vaccines help reduce the spread of COVID-19 and resulting deaths, there have not been many good or easy treatment options for the actual virus. But a new antiviral drug from Merck offers hope for keeping patients infected with COVID-19 out of the hospital and alive. Dr. Nahid Bhadelia, an infectious disease specialist at Boston University, joins William Brangham to discuss.

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour

Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe